Lumexa Imaging (NASDAQ:LMRI) Stock Price Down 12.7% – Here’s Why

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)’s stock price fell 12.7% during mid-day trading on Wednesday . The company traded as low as $8.91 and last traded at $9.1640. 211,733 shares traded hands during trading, a decline of 73% from the average session volume of 790,108 shares. The stock had previously closed at $10.50.

Analysts Set New Price Targets

LMRI has been the subject of a number of research reports. Barclays reduced their price objective on Lumexa Imaging from $23.00 to $15.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Raymond James Financial raised shares of Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 target price on the stock in a report on Monday, February 9th. Finally, Weiss Ratings began coverage on shares of Lumexa Imaging in a research report on Wednesday. They issued a “sell (e-)” rating for the company. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the company. According to MarketBeat, Lumexa Imaging currently has a consensus rating of “Moderate Buy” and an average target price of $19.00.

Lumexa Imaging Stock Performance

The business has a fifty day moving average price of $10.51.

Hedge Funds Weigh In On Lumexa Imaging

A number of large investors have recently modified their holdings of the business. T. Rowe Price Investment Management Inc. purchased a new stake in shares of Lumexa Imaging in the fourth quarter valued at approximately $37,139,000. Janus Henderson Group PLC acquired a new stake in Lumexa Imaging in the fourth quarter valued at $36,860,000. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Lumexa Imaging during the 4th quarter worth $27,750,000. ArrowMark Colorado Holdings LLC acquired a new position in shares of Lumexa Imaging during the 4th quarter worth $27,750,000. Finally, Invesco Ltd. acquired a new position in shares of Lumexa Imaging during the 4th quarter worth $26,562,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).